This is our second civil society-led monitoring of harm reduction report. With more than one hundred contributors and Focal Points from 34 European countries involved, the report aims to make a necessary and useful contribution to the development of drug policy in the region.

Compared to 2019’s report, the information provided in 2020, brings to the forefront of the situation in particular cities or regions showing the experiences of harm reduction providers on the ground. We also bring direct perspectives of people who use drugs. This significant approach will hopefully provide an understanding of the successes and challenges of drug policy and harm reduction implementation.

Hereby, we would like to thank all contributors for their great work and commitment.

We will use the insights and information collected in this report within our advocacy efforts to strengthen harm reduction policies in Europe and, we hope that you will do the same at a regional and national level.

Monitored Focus Areas:
Participation of Civil Society Organisations in policymaking
Essential Harm Reduction Services
Hepatitis C
Overdose Prevention
Highlights in New Drug Trends
COVID-19 and Harm Reduction

Read the Report